Last Posted: Dec 20, 2018
- Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.
Brunham Liam R et al. The Canadian journal of cardiology 2018 Dec 34(12) 1553-1563 - Impact of biobanks on research outcomes in rare diseases: a systematic review.
Garcia Monique et al. Orphanet journal of rare diseases 2018 Nov 13(1) 202 - New ACC/AHA Cholesterol Guideline Allows For More Personalized Care; New Treatment Options
American College of Cardiology, November 10, 2018 - South African dyslipidaemia guideline consensus statement: 2018 update A joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA).
Klug E et al. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2018 Oct 108(11b) 973-1000 - Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.
Lloyd-Jones Donald M et al. Journal of the American College of Cardiology 2018 Nov - Familial Hypercholesterolemia: Clinician and Patient Insights
American College of Cardiology, October 2018 - Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.
Peyser Bruce et al. Circulation. Genomic and precision medicine 2018 Sep 11(9) e002228 - Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients.
Tryggvadottir Helga et al. Frontiers in oncology 2018 8428 - Pharmacogenomics: What does it mean for your health
CDC, October 2018 - Distinguishing genetic correlation from causation across 52 diseases and complex traits.
O'Connor Luke J et al. Nature genetics 2018 Oct
.png)
No hay comentarios:
Publicar un comentario